Back

Bivalirudin versus Heparin in ST and non-ST-segment elevation myocardial infarction

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis
Professor J. Silvain (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.
Ms E. Woelders (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Successful ESC recommended LDL-C reduction after percutaneous coronary intervention: real-world data from the contemporary ZON-HR registry.
Ms D. Peeters (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources